This inventor holds 2 USPTO granted patents. Top assignees: Human Genome Sciences, Inc., Smithkline Beecham Corporation, Other. Active years: 2002-2005.
Company Filing History:
1 out of 676 
1 out of 2,198 
1 out of 834,307 Years Active: 2002-2005
Title: Solange H L Gentz: Innovator in Chemokine Research
Introduction
Solange H L Gentz is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biochemistry, particularly in the development of chemokine polypeptides. With a total of 2 patents, his work has implications for various medical treatments.
Latest Patents
Gentz's latest patents focus on human chemokine beta-10 mutant polypeptides. These patents disclose the DNA (RNA) encoding such chemokine polypeptides and a procedure for producing them through recombinant techniques. The methods outlined in these patents are aimed at utilizing these chemokine polypeptides for the treatment of leukemia, tumors, chronic infections, autoimmune diseases, fibrotic disorders, wound healing, and psoriasis. Additionally, the patents describe antagonists against these chemokine polypeptides and their therapeutic applications for treating rheumatoid arthritis, autoimmune and chronic inflammatory diseases, allergic reactions, prostaglandin-independent fever, and bone marrow failure.
Career Highlights
Throughout his career, Solange H L Gentz has worked with prominent companies in the biotechnology sector, including Human Genome Sciences, Inc. and SmithKline Beecham Corporation. His experience in these organizations has contributed to his expertise in the field of chemokine research.
Collaborations
Gentz has collaborated with notable colleagues such as Henrik S Olsen and Haodong Li. These collaborations have further enriched his research and development efforts in the field.
Conclusion
Solange H L Gentz is a distinguished inventor whose work in chemokine polypeptides has the potential to advance medical treatments for various diseases. His contributions to the field are invaluable and continue to influence ongoing research.